Skip to main content
. 2001 Oct;45(10):2703–2709. doi: 10.1128/AAC.45.10.2703-2709.2001

TABLE 2.

Effect of C-8 substituents on lethal action of fluoroquinolones

Fluoroquinolonea C-7 ring alkylb LD90 (μg/ml)c
M. smegmatis
S. aureus
gyrA+ gyrA parC+ gyrA+ parC gyrA
Ciprofloxacin (H) 0.6 >120 0.28 >320
PD129603 (Cl) 0.19 11 0.07 9.4
PD1380232 (H) Me 0.38 >120 0.34 320
PD125275 (F) Me 0.29 12 0.27 >320
PD163753 (Br) Me 0.38 7.2 0.23 7.5
PD138124 (Cl) Me 0.25 9.0 0.32 9.0
PD135432 (OMe) Me 0.22 8.0 0.21 7.3
PD158804 (H) di-Me 0.37 >120 0.47 >320
PD125232 (F) di-Me 0.36 100 0.31 35
Bay y 3114 (H) NA 0.15 120 0.07 >320
Moxifloxacin (OMe) NA 0.28 12 0.08 5.2
a

Parenthetical information indicates moiety at the C-8 position. PD135432 is identical to gatifloxacin. OMe, methoxy. 

b

Alkyls attached to C-7 ring. NA, not applicable because the C-7 ring systems are not comparable with other members of the set (see Fig. 1). 

c

Concentration required to reduce survival by 90% as determined from Fig. 2 to 5. Similar results were obtained in two independent experiments. The S. smegmatis strains were mc2155 (gyrA+) and KD2003 (gyrA); the S. aureus strains were ISP794 (parC+ gyrA+) and EN1252 (parC gyrA). In S. aureus parC was originally designated grlA